on RedChip Companies, Inc. (Media Suite) (NASDAQ:JUNS)
BioAffinity and Can-Fite Interviews to Broadcast on Bloomberg TV
RedChip Companies has announced that interviews with bioAffinity Technologies and Can-Fite BioPharma will be featured on the RedChip Small Stocks, Big Money™ show via Bloomberg TV. Scheduled for March 29 at 7 p.m. ET, the broadcast reaches approximately 73 million homes in the U.S.
Maria Zannes, CEO of bioAffinity Technologies, will provide a corporate update. The company aims to improve lung cancer diagnosis with its product, CyPath® Lung. This tool could enhance early detection, reduce unnecessary procedures, and lower medical costs. bioAffinity recently secured a U.S. Federal Supply Schedule contract, broadening access to this diagnostic test.
Can-Fite CEO Motti Farbstein will discuss the company's development pipeline, which includes strategic out-licensing deals and several trials for innovative treatments targeting markets worth over $70 billion. Can-Fite has received $20 million in upfront payments.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all RedChip Companies, Inc. (Media Suite) news